Hemostemix Inc. announced a private placement of 2,709,375 units at a price of CAD 0.12 per unit for the gross proceeds of CAD 325,125 on September 28, 2023. Each unit will consist of one common share and one half of one common share purchase warrant with each full warrant entitling the holder to acquire one common share at a price of CAD 0.25 per common share for a period of 24 months from the closing of the offering. The private placement is subject to all necessary regulatory approvals including acceptance from the exchange.

All securities issued under the Private Placement will be subject to a four-month hold period from the closing date under applicable Canadian securities laws, in addition to such other restrictions as may apply.